Modified vein allograft for small arterial reconstruction in dogs
Tóm tắt
The ideal graft for peripheral arterial reconstruction has yet to be developed. We evaluated on the effectiveness of porosity to intimization of the graft. Modified vein allografts newly constructed through digestion of vein allografts with elastase, glutaraldehyde tanning and lyophilization were implanted in thirty-nine canine femoral arteries. These grafts had a higher porosity than conventional vein allografts and the overall patency rate was 70 per cent at 6 months after implantation. Microscopic examination showed that graft interstitial healing and subsequent intimization were completed by ingrowth of connective tissue from outside through the graft wall at 3 weeks and later. Aneurysmal change of the modified vein allografts was never evident. These results indicated that porosity of the graft is indeed an important factor for intimization and durability of grafts, even in bioderivative substitutes.
Tài liệu tham khảo
Szilagyi DE. Some controversial topics in vascular surgery. Am J Surg 1969; 118: 406–412.
Rosenberg N, Gaughran ERL, Henderson J, Lord GH, Douglas JF. The use of segmental arterial implants prepared by enzymatic modification of heterologous blood vessels. Surg Forum 1956; 6: 242–246.
DeFalco RJ. Immunologic studies of untreated and chemically modified bovine carotid arteries. J Surg Res 1970; 10: 95–100.
Dardik H, Veith FJ, Spreyregen S, Dardik I. Arterial reconstruction with modified collagen tube, a clinical experience. Ann Surg 1974; 180: 144–146.
Kubo Y, Sasajima T, Atsuta T, Ikeda H, Nishioka Y, Izumi Y, Inaba M, Matsushita M, Samejima N. Early clinical results of the modified human umbilical cord vein homograft (Dardik Biograft). J Cardiovasc Surg 1983; 24: 101–106.
Dardik H, Dardik I. Successful arterial substitution with modified human umbilical vein. Ann Surg 1976; 183: 252–258.
Mindich B, Silverman M, Elguezabel A, Flores L, Sheka RP, Levowitz BS. Human umbilical cord vein for vascular replacement, preliminary report and observations. Surgery 1977; 81: 152–160.
Giordano JM, Keshishian JM. Aneurysm formation in human umbilical vein grafts. Surgery 1982; 91: 343–345.
Baló J, Banga I. The elastolytic activity of pancreatic extracts. Biochem J 1959; 46: 384–387.
Shotton DM. Elastase. In: Colowick SP, Kaplan NO. eds. Methods in Enzymology. New York: Academic Press, 1970; 19: 140.
Naughton MA, Sanger F. Purification and specificity of pancreatic elastase. Biochem J 1961; 78: 156–163.
Cohn LH, Sanders Jr JH, Collins Jr JJ. Aortic valve replacement with the Hancock porcine xenograft. Ann Thorac Surg 1976; 22: 221–227.
Foster JH, Lance EM, Scott HW. Experience with ethylene oxide treated freeze-dry arterial homografts in 110 consective patients. Ann Surg 1958; 148: 230–238.
Szilagyi DE, McDonald RT, Smith RF, Whitcomb JG. Biologic fate of human arterial homografts. Arch Surg 1957; 75: 506–529.
Calhoun AD, Baur GM, Porter JM, Houghton DH, Templeton JW. Fresh and cryopreserved venous allografts in genetically characterized dogs. J Surg Res 1977; 22: 687–696.
Weber TR, Dent TL, Salles CA, Ramsburgh SR, Fonseca FP, Lindenauer SM. Cryopreservation of venous homografts. Surg Forum 1975; 36: 291–293.
Ochsner JL, DeCamp PT, Leonard GL. Experience with fresh venous allografts as an arterial substitute. Ann Surg 1971; 173: 933–939.
Ochsner JL. In discussion of Williams GM, ter Harr A, Krajewski C, Parks LC, Roth J. Rejection and repair of endothelium in major vessel transplants. Surgery 1975; 78: 694–706.
Kusaba A, Inokuchi K, Mutoh Y, Morinaga M, Furuyama M, Kamori M, Kina M. Long-term results of reconstructive surgery for femoro-popliteal arterial occlusive regions. Jpn J Surg 1980; 10: 245–250.
Dardik H, Ibrahim IM, Sussman B, Jarrah M, Dardik I. Glutaraldehyde-stabilized umbilical vein prosthesis for revascularization of the legs, three year results by life table analysis. Am J Surg 1979; 138: 234–237.
Simone Jr ST, Dubner B, Safi AR, DelGuercio P, Shah MA, Zagorin L, Reichle FA. Comparative review of early and intermediate patency rates of polytetrafluoroethylene and autogenous saphenous vein grafts for lower extremity ischemia. Surgery 1981; 90: 991–999.
Kambic H, Picha G, Kiraly R, Koshino I, Nosé Y. Application of aldehyde treatments to cardiovascular devices. Trans Amer Soc Artifi Int Organs 1976; 22: 664–672.
Dardik H, Ibrahim IM, Sussman B, Kahn M, Sanchez M, Klansner S, Baier RE, Meyer AE, Dardik I. Biodegradation and aneurysm formation in umbilical cord vein grafts, observation and a realistic strategy. Ann Surg 1984; 199: 61–68.
Sauvage LR, Berger KE, Wood SJ, Yates II SG, Smith JC, Mansfield PB. Interspecies healing of porous arterial prostheses, observations, 1960 to 1974. Arch Surg 1974; 109: 698–705.
Szilagyi DE. Discussion on graft materials. In: Dardik H. ed. Graft materials in vascular surgery. Miami: Symposia Specialists, Inc., 1978; 307–319.
Dardik H, Ibrahim IM, Sprayregen S, Dardik I. Clinical experience with modified human umbilical cord vein for arterial bypass. Surgery 1976; 79: 618–624.
Carpenter EW, Lindenauer SM. Immunosuppression in arterial and venous allografts. Arch Surg 1973; 106: 75–78.
Barner HB, DeWeese JA, Schenk EA. Fresh and frozen homologous venous grafts for arterial repair. Angiology 1966; 17: 389–401.
Feins RH, Roedersheimer LR, Green RM, DeWeese JA. Platelet aggregation inhibition in human umbilical vein grafts and negatively charged bovine heterografts. Surgery 1979; 85: 395–399.
Oblath RW, Buckley FO, Donnelly WA, Green RM, DeWeese JA. Human umbilical veins and autogenous veins as canine arterial bypass grafts. Ann Surg 1978; 188: 158–161.